The CORRONA Data Collection Program

Trial Profile

The CORRONA Data Collection Program

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Nov 2017

At a glance

  • Drugs Abatacept (Primary) ; Rituximab (Primary) ; Tocilizumab (Primary) ; Adalimumab; Antirheumatics; Disease-modifying antirheumatics; Prednisone; Tumour necrosis factor inhibitors
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Nov 2017 Results (n=3182) assessing rate of serious infection events in patients with presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
    • 08 Nov 2017 Results comparing efficacy of Tocilizumab monotherapy with TNFi +methotrexate, presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
    • 08 Nov 2017 Results assessing the response to Adalimumab in biologic-naive patients with rheumatoid arthritis (n=1949) presented at the 81st American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top